<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: CordenPharma &#038; Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna&#8217;s Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2 	</title>
	<atom:link href="https://www.newpharmaitaly.it/cordenpharma-moderna-extend-strategic-manufacturing-services-agreement-for-the-supply-of-lipid-excipients-to-be-used-in-modernas-vaccine-mrna-1273-against-the-novel-coronavirus-sars-cov-2/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/cordenpharma-moderna-extend-strategic-manufacturing-services-agreement-for-the-supply-of-lipid-excipients-to-be-used-in-modernas-vaccine-mrna-1273-against-the-novel-coronavirus-sars-cov-2/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Thu, 28 May 2020 03:30:58 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
